Special Offer
Healthy Smiles for a Healthy Life - Book an Appointment!
TuMatch analyzes the genetic and molecular profile of your tumour to pinpoint the therapies most likely to work for you.
For complex cases, we explore novel treatment combinations, including the use of non-cancer drugs, to maximize your options.
Our current focus is on colorectal, pancreatic, and other gastrointestinal (GI) cancers, ensuring deep expertise and targeted solutions.
Matching specific genetic signatures with Vivan’s proprietary treatment data
Best suited Standard of Care. Treatments in clinical trials. Novel more efficient therapies
Our one-of-a-kind process provides individuals with treatment-driven research on an unprecedented scale. Leveraging the power of AI and research from 80 million animal studies we can evaluate as many as 2,000 FDA/NICE approved drugs (including non-cancer drugs), to identify drug combinations that are most likely to work.
1. Identify novel drug combinations
That are less toxic and more effective than generic treatment
2. Reduce the size of target
3. Extend life expectancy
TuMatch empowers patients and their care teams to make informed, confident decisions. Schedule a free call with ourexperts to learn how TuMatch can help you or your loved one.
